Predictions
Infineon Technologies AG
Start price
Target price
Perf. (%)
€35.63
20.09.21
20.09.21
€44.00
20.09.22
20.09.22
8.39%
27.10.21
27.10.21
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.50
20.09.21
20.09.21
-
20.09.22
20.09.22
29.09%
21.09.21
21.09.21
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.84
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-13.38%
02.10.21
02.10.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
United Insurance Holdings Corp
Start price
Target price
Perf. (%)
€2.62
20.09.21
20.09.21
€3.50
20.09.22
20.09.22
39.69%
18.10.21
18.10.21
Known brand
Probably not worthwhile Investment
Higher risks for its business
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-22.69%
22.10.21
22.10.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
Erste Group Bank AG
Start price
Target price
Perf. (%)
€34.76
20.09.21
20.09.21
-
20.09.22
20.09.22
-27.22%
21.09.22
21.09.22
Could be worthwhile Investment >10% per year
Very good company culture
Very capable Management
Innovative
Verastem Inc.
Start price
Target price
Perf. (%)
€34.22
20.09.21
20.09.21
€60.00
31.12.23
31.12.23
-88.71%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Vitesco Technologies Group AG
Start price
Target price
Perf. (%)
€62.45
19.09.21
19.09.21
€69.00
19.09.22
19.09.22
-16.57%
20.09.22
20.09.22
Could be worthwhile Investment >10% per year
Good rating
Standard Investments for future growth
Top 10 in its market
Amundi S.A.
Start price
Target price
Perf. (%)
€75.10
19.09.21
19.09.21
€60.00
19.09.22
19.09.22
-0.47%
09.10.21
09.10.21
Could be worthwhile Investment >10% per year
Air Liquide S.A.
Start price
Target price
Perf. (%)
€143.94
19.09.21
19.09.21
€148.00
19.09.22
19.09.22
-15.40%
20.09.22
20.09.22
Could be worthwhile Investment >10% per year
Air Liquide S.A.
Start price
Target price
Perf. (%)
€143.94
19.09.21
19.09.21
€148.00
19.09.22
19.09.22
-15.40%
20.09.22
20.09.22
Could be worthwhile Investment >10% per year
Air Liquide S.A.
Start price
Target price
Perf. (%)
€143.94
19.09.21
19.09.21
€148.00
19.09.22
19.09.22
-15.40%
20.09.22
20.09.22
Could be worthwhile Investment >10% per year
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€35.60
19.09.21
19.09.21
€60.00
19.09.22
19.09.22
28.37%
16.06.22
16.06.22
MacroGenics Inc.
Start price
Target price
Perf. (%)
€16.79
19.09.21
19.09.21
-
19.09.22
19.09.22
-79.51%
20.09.22
20.09.22
Probably not worthwhile Investment
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€25.05
19.09.21
19.09.21
-
19.09.22
19.09.22
-85.23%
20.09.22
20.09.22
Growths faster than the competition
Risky Investment
Celyad SA ADR
Start price
Target price
Perf. (%)
€3.58
19.09.21
19.09.21
-
19.09.22
19.09.22
-53.35%
20.09.22
20.09.22
Probably not worthwhile Investment
Heat Biologics Inc.
Start price
Target price
Perf. (%)
€5.30
18.09.21
18.09.21
-
18.09.22
18.09.22
-63.56%
19.09.22
19.09.22
Risky Investment
High risks for its business
Dependend from few customers or products
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
18.09.21
18.09.21
€10.00
31.12.23
31.12.23
-79.42%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€12.54
18.09.21
18.09.21
€20.00
31.12.23
31.12.23
-52.05%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Spectrum Pharmaceuticals
Start price
Target price
Perf. (%)
€2.60
18.09.21
18.09.21
€5.00
31.12.23
31.12.23
-62.67%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
18.09.21
18.09.21
€2.00
18.09.22
18.09.22
-22.69%
02.10.21
02.10.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation